Eli Lilly and Company (LLY) Q1 2026 (USD): Adj. EPS 8.55 (exp. 6.88), Revenue 19.8bln (exp. 17.68bln), Mounjaro 8.66bln, Zepbound 4.16bln
Importance
Level 1
Guidance:
- FY adj. EPS 35.50-37 (exp. 34.52).
- FY revenue 82-85bln (exp. 82.1bln).
© 2026 Newsquawk. All rights reserved.